Interpace Biosciences, Inc. (MUN:PF42)
Germany flag Germany · Delayed Price · Currency is EUR
1.370
0.00 (0.00%)
At close: Mar 13, 2026

Interpace Biosciences Statistics

Total Valuation

MUN:PF42 has a market cap or net worth of EUR 41.80 million. The enterprise value is 42.53 million.

Market Cap 41.80M
Enterprise Value 42.53M

Important Dates

The next estimated earnings date is Friday, March 20, 2026.

Earnings Date Mar 20, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 27.69M
Shares Outstanding n/a
Shares Change (YoY) +654.43%
Shares Change (QoQ) +526.16%
Owned by Insiders (%) 3.49%
Owned by Institutions (%) 0.52%
Float 3.46M

Valuation Ratios

The trailing PE ratio is 14.71.

PE Ratio 14.71
Forward PE n/a
PS Ratio 1.17
PB Ratio -164.58
P/TBV Ratio n/a
P/FCF Ratio 11.07
P/OCF Ratio 10.06
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.76, with an EV/FCF ratio of 11.26.

EV / Earnings 14.96
EV / Sales 1.17
EV / EBITDA 8.76
EV / EBIT 10.73
EV / FCF 11.26

Financial Position

The company has a current ratio of 1.54

Current Ratio 1.54
Quick Ratio 1.24
Debt / Equity n/a
Debt / EBITDA 0.40
Debt / FCF 0.51
Interest Coverage 17.11

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 21.90%
Return on Invested Capital (ROIC) 462.35%
Return on Capital Employed (ROCE) 75.00%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 321,839
Profits Per Employee 25,607
Employee Count 111
Asset Turnover 3.21
Inventory Turnover 13.70

Taxes

Income Tax -852
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 1.21
200-Day Moving Average n/a
Relative Strength Index (RSI) 100.00
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.01

Income Statement

In the last 12 months, MUN:PF42 had revenue of EUR 35.72 million and earned 2.84 million in profits. Earnings per share was 0.08.

Revenue 35.72M
Gross Profit 22.15M
Operating Income 3.89M
Pretax Income 3.49M
Net Income 2.84M
EBITDA 4.24M
EBIT 3.89M
Earnings Per Share (EPS) 0.08

Balance Sheet

The company has 1.21 million in cash and 1.93 million in debt, with a net cash position of -713,375.

Cash & Cash Equivalents 1.21M
Total Debt 1.93M
Net Cash -713,375
Net Cash Per Share n/a
Equity (Book Value) -253,985
Book Value Per Share -0.06
Working Capital 2.71M

Cash Flow

In the last 12 months, operating cash flow was 4.16 million and capital expenditures -380,978, giving a free cash flow of 3.78 million.

Operating Cash Flow 4.16M
Capital Expenditures -380,978
Free Cash Flow 3.78M
FCF Per Share n/a

Margins

Gross margin is 62.01%, with operating and profit margins of 10.90% and 9.06%.

Gross Margin 62.01%
Operating Margin 10.90%
Pretax Margin 9.77%
Profit Margin 9.06%
EBITDA Margin 11.86%
EBIT Margin 10.90%
FCF Margin 10.57%

Dividends & Yields

MUN:PF42 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -654.43%
Shareholder Yield -654.43%
Earnings Yield 6.80%
FCF Yield 9.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MUN:PF42 has an Altman Z-Score of -21.79 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -21.79
Piotroski F-Score 6